These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8775838)
41. Pharmacokinetic considerations in the maternal-placental-fetal unit. Juchau MR; Faustman-Watts E Clin Obstet Gynecol; 1983 Jun; 26(2):379-90. PubMed ID: 6851290 [No Abstract] [Full Text] [Related]
42. Clinical effects of pharmacologic agents on pregnancy, the fetus, and the neonate. Finnegan L Ann N Y Acad Sci; 1976; 281():74-89. PubMed ID: 798531 [No Abstract] [Full Text] [Related]
43. [Characteristics of drug use during pregnancy]. Kiriushchenkov AP Feldsher Akush; 1988 Mar; 53(3):21-8. PubMed ID: 3378636 [No Abstract] [Full Text] [Related]
44. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Krauer B; Krauer F; Hytten FE Pharmacol Ther; 1980; 10(2):301-28. PubMed ID: 7413726 [No Abstract] [Full Text] [Related]
45. Pharmacology of drug transfer across the placenta. Garland M Obstet Gynecol Clin North Am; 1998 Mar; 25(1):21-42. PubMed ID: 9547758 [TBL] [Abstract][Full Text] [Related]
46. Transmission of drugs by the placenta and the breasts. Smithells RW; Morgan DM Practitioner; 1970 Jan; 204(219):14-9. PubMed ID: 5411150 [No Abstract] [Full Text] [Related]
51. [Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]. Panchaud A; Weisskopf E; Winterfeld U; Baud D; Guidi M; Eap CB; Csajka C; Widmer N Therapie; 2014; 69(3):223-34. PubMed ID: 25011648 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic correlates of fetal drug exposure. DeVane CL NIDA Res Monogr; 1991; 114():18-36. PubMed ID: 1754013 [No Abstract] [Full Text] [Related]
53. Placental drug transfer: effects of gestational age and species. Mihaly GW; Morgan DJ Pharmacol Ther; 1983; 23(2):253-66. PubMed ID: 6366827 [TBL] [Abstract][Full Text] [Related]
54. [Pharmacokinetics, drug availability and clinical pharmacology of bromhexine]. Renovanz HD Wien Klin Wochenschr; 1973 Sep; 123(37):Suppl 7:1-8. PubMed ID: 4201509 [No Abstract] [Full Text] [Related]
55. [Pharmacology for the fetus and the newborn]. Juárez-Olguín H; Buendía-Soto E; Lares-Asseff I Gac Med Mex; 2015; 151(3):387-95. PubMed ID: 26089275 [TBL] [Abstract][Full Text] [Related]
56. Drugs used in pregnancy: the regulatory process. Tomalin A Can J Clin Pharmacol; 2007; 14(1):e5-9. PubMed ID: 17213510 [No Abstract] [Full Text] [Related]
57. The transfer of drugs across the placenta. Long RF; Marks J Proc R Soc Med; 1969 Apr; 62(4):318-21. PubMed ID: 5811928 [No Abstract] [Full Text] [Related]
58. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Lozano J; García-Algar O; Vall O; de la Torre R; Scaravelli G; Pichini S Ther Drug Monit; 2007 Dec; 29(6):711-34. PubMed ID: 18043469 [TBL] [Abstract][Full Text] [Related]
59. Drug misuse during pregnancy and fetal toxicity. Anderson M; Choonara I Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F332-3. PubMed ID: 17712182 [TBL] [Abstract][Full Text] [Related]
60. [Structure of the placenta during fetal development]. Fredricsson B Nord Med; 1967 Oct; 78(42):1351-3. PubMed ID: 5590746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]